A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

Clinical trial NCT04671615 · COMPLETED

Trial details

NCT number: NCT04671615
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2020-12-06
Primary completion: 2022-11-30
Enrollment: 559

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.